These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6220605)

  • 1. Down syndrome--a disruption of homeostasis.
    Shapiro BL
    Am J Med Genet; 1983 Feb; 14(2):241-69. PubMed ID: 6220605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome.
    Pritchard MA; Kola I
    J Neural Transm Suppl; 1999; 57():293-303. PubMed ID: 10666684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental consequences of autosomal aneuploidy in mammals.
    Gearhart JD; Oster-Granite ML; Reeves RH; Coyle JT
    Dev Genet; 1987; 8(4):249-65. PubMed ID: 2971493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
    Annerén G; Edman B
    APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic mechanisms involved in the phenotype of Down syndrome.
    Patterson D
    Ment Retard Dev Disabil Res Rev; 2007; 13(3):199-206. PubMed ID: 17910086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aneuploidy: from a physiological mechanism of variance to Down syndrome.
    Dierssen M; Herault Y; Estivill X
    Physiol Rev; 2009 Jul; 89(3):887-920. PubMed ID: 19584316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down syndrome mouse models are looking up.
    Reeves RH
    Trends Mol Med; 2006 Jun; 12(6):237-40. PubMed ID: 16677859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human chromosome 21q22.2-qter carries a gene(s) responsible for downregulation of mlc2a and PEBP in Down syndrome model mice.
    Kazuki Y; Kimura M; Nishigaki R; Kai Y; Abe S; Okita C; Shirayoshi Y; Schulz TC; Tomizuka K; Hanaoka K; Inoue T; Oshimura M
    Biochem Biophys Res Commun; 2004 Apr; 317(2):491-9. PubMed ID: 15063784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
    Rachidi M; Lopes C
    Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
    Rachidi M; Lopes C
    Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between genetic anomalies of different levels and deviations in dermatoglyphic traits. Part 4: Dermatoglyphic peculiarities of males and females with Down syndrome. Family study.
    Katznelson MB; Bejerano M; Yakovenko K; Kobyliansky E
    Anthropol Anz; 1999 Sep; 57(3):193-255. PubMed ID: 10584152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double aneuploidy (48,XXY,+21) of maternal origin in a child born to a 13-year-old mother: evaluation of the maternal folate metabolism.
    Biselli JM; Machado FB; Zampieri BL; Alves da Silva AF; Goloni-Bertollo EM; Haddad R; Eberlin MN; Vannucchi H; Carvalho VM; Medina-Acosta E; Pavarino-Bertelli EC
    Genet Couns; 2009; 20(3):225-34. PubMed ID: 19852428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.
    Richtsmeier JT; Baxter LL; Reeves RH
    Dev Dyn; 2000 Feb; 217(2):137-45. PubMed ID: 10706138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal balanced translocation (4;21) leading to an offspring with partial duplication of 4q and 21q without phenotypic manifestations of Down syndrome.
    El-Ruby M; Hemly NA; Zaki MS
    Genet Couns; 2007; 18(2):217-26. PubMed ID: 17710874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using mouse models to explore genotype-phenotype relationship in Down syndrome.
    Salehi A; Faizi M; Belichenko PV; Mobley WC
    Ment Retard Dev Disabil Res Rev; 2007; 13(3):207-14. PubMed ID: 17910089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluctuating dental asymmetry: a measure of developmental instability in Down syndrome.
    Barden HS
    Am J Phys Anthropol; 1980 Feb; 52(2):169-73. PubMed ID: 6445164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of chromosome 21 in a patient with a phenotype of Down syndrome and apparently normal karyotype.
    Ahlbom BE; Goetz P; Korenberg JR; Pettersson U; Seemanova E; Wadelius C; Zech L; Annerén G
    Am J Med Genet; 1996 Jun; 63(4):566-72. PubMed ID: 8826436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Down syndrome: pathogenesis, radioresistant DNA synthesis and chromosomal instability].
    Barenfel'd LS
    Tsitologiia; 2002; 44(4):379-86. PubMed ID: 12149783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trisomy of chromosome 21 in leukemogenesis.
    Izraeli S; Rainis L; Hertzberg L; Smooha G; Birger Y
    Blood Cells Mol Dis; 2007; 39(2):156-9. PubMed ID: 17532652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III).
    Cheon MS; Kim SH; Ovod V; Kopitar Jerala N; Morgan JI; Hatefi Y; Ijuin T; Takenawa T; Lubec G
    Amino Acids; 2003; 24(1-2):127-34. PubMed ID: 12624744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.